{"id":22962,"date":"2025-05-07T20:02:05","date_gmt":"2025-05-07T20:02:05","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/benchling-and-moderna-collaborate-on-ai-driven-research\/"},"modified":"2025-05-07T20:02:05","modified_gmt":"2025-05-07T20:02:05","slug":"benchling-and-moderna-collaborate-on-ai-driven-research","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=22962","title":{"rendered":"Benchling and Moderna Collaborate on AI-Driven Research"},"content":{"rendered":"<p> <span class=\"legendSpanClass\">SAN FRANCISCO and BOSTON<\/span>, <span class=\"legendSpanClass\">May 7, 2025<\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4421373-1&amp;h=2677276496&amp;u=https%3A%2F%2Fwww.benchling.com%2F&amp;a=Benchling%2C\" target=\"_blank\" rel=\"nofollow\">Benchling,<\/a> the R&amp;D platform powering the biotech industry, today announced an expanded collaboration with <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4421373-1&amp;h=1617275507&amp;u=https%3A%2F%2Fwww.modernatx.com%2Fen-US&amp;a=Moderna\" target=\"_blank\" rel=\"nofollow\">Moderna<\/a>. What began with Benchling supporting Moderna&#8217;s technical development teams \u2014 such as analytical development, technical operations, process development, and formulations \u2014 has grown into a broader rollout across the company&#8217;s research organization. The expansion will bring hundreds of Moderna&#8217;s scientists onto a unified, AI-ready research and development digital platform built to accelerate discovery and innovation.<\/p>\n<p>&#8220;Moderna was built on the belief that technology and science together drive breakthroughs in medicine,&#8221; said Wade Davis, Senior Vice President, Digital at Moderna. &#8220;AI is creating extraordinary opportunities in science, but realizing its full potential requires entirely new ways of working. Benchling is tackling these industry-wide challenges head-on. Through this collaboration, our scientists have access to a strong foundation for AI and our computational scientists and engineers are empowered to do truly cutting-edge work.&#8221;<\/p>\n<p> <b> A new standard for digital transformation in biotech <\/b> <\/p>\n<p>Moderna and Benchling are focused on three priorities with this digital transformation: consolidating systems to create a seamless experience for scientists, automating scientific workflows, and standardizing data into consistent, AI-ready formats.<\/p>\n<p>&#8220;R&amp;D teams are under constant pressure to move faster and work more efficiently. AI and automation can unlock new levels of productivity, but only with the right infrastructure,&#8221; said Sajith Wickramasekara, CEO and co-founder of Benchling. &#8220;Moderna and Benchling are showing what the future of R&amp;D looks like\u2014fully digital, deeply integrated and built for intelligence and scale.&#8221;<\/p>\n<p> <b> Innovating the infrastructure for AI in biotech <\/b> <\/p>\n<p>Moderna&#8217;s research and technical development teams required a flexible system that could scale with their pipeline. Benchling&#8217;s digital platform addresses these needs by balancing agility with out-of-the box scientific workflows. Moderna&#8217;s digital teams use Benchling&#8217;s developer platform to build and deploy custom workflows, automate template generation, and integrate proprietary machine learning models. This shift reduces setup time for new workflows and enables high-throughput processing of experimental data\u2014allowing digital teams to focus on innovation instead of maintaining systems.\u00a0<\/p>\n<p>As Benchling rolls out across the research organization, scientists can design experiments, track samples, and analyze results within a single system, eliminating the friction of disconnected tools. The platform also addresses a long-standing industry challenge: integrating both structured and unstructured data across diverse research environments, laying the groundwork for AI-driven analysis across therapeutic areas.<\/p>\n<p>Through this collaboration, the two companies are redefining how modern biotech research is done, setting a new standard for the digital infrastructure behind AI-driven R&amp;D.<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> <span class=\"legendSpanClass\">SAN FRANCISCO and BOSTON<\/span>, <span class=\"legendSpanClass\">May 7, 2025<\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4421373-1&amp;h=2677276496&amp;u=https%3A%2F%2Fwww.benchling.com%2F&amp;a=Benchling%2C\" target=\"_blank\" rel=\"nofollow\">Benchling,<\/a> the R&amp;D platform powering the biotech industry, today announced an expanded collaboration with <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4421373-1&amp;h=1617275507&amp;u=https%3A%2F%2Fwww.modernatx.com%2Fen-US&amp;a=Moderna\" target=\"_blank\" rel=\"nofollow\">Moderna<\/a>. What began with Benchling supporting Moderna&#8217;s technical development teams \u2014 such as analytical development, technical operations, process development, and formulations \u2014 has grown into a broader rollout across the company&#8217;s research organization. The expansion will bring hundreds of Moderna&#8217;s scientists onto a unified, AI-ready research and development digital platform built to accelerate discovery and innovation.<\/p>\n<p>&#8220;Moderna was built on the belief that technology and science together drive breakthroughs in medicine,&#8221; said Wade Davis, Senior Vice President, Digital at Moderna. &#8220;AI is creating extraordinary opportunities in science, but realizing its full potential requires entirely new ways of working. Benchling is tackling these industry-wide challenges head-on. Through this collaboration, our scientists have access to a strong foundation for AI and our computational scientists and engineers are empowered to do truly cutting-edge work.&#8221;<\/p>\n<p> <b> A new standard for digital transformation in biotech <\/b> <\/p>\n<p>Moderna and Benchling are focused on three priorities with this digital transformation: consolidating systems to create a seamless experience for scientists, automating scientific workflows, and standardizing data into consistent, AI-ready formats.<\/p>\n<p>&#8220;R&amp;D teams are under constant pressure to move faster and work more efficiently. AI and automation can unlock new levels of productivity, but only with the right infrastructure,&#8221; said Sajith Wickramasekara, CEO and co-founder of Benchling. &#8220;Moderna and Benchling are showing what the future of R&amp;D looks like\u2014fully digital, deeply integrated and built for intelligence and scale.&#8221;<\/p>\n<p> <b> Innovating the infrastructure for AI in biotech <\/b> <\/p>\n<p>Moderna&#8217;s research and technical development teams required a flexible system that could scale with their pipeline. Benchling&#8217;s digital platform addresses these needs by balancing agility with out-of-the box scientific workflows. Moderna&#8217;s digital teams use Benchling&#8217;s developer platform to build and deploy custom workflows, automate template generation, and integrate proprietary machine learning models. This shift reduces setup time for new workflows and enables high-throughput processing of experimental data\u2014allowing digital teams to focus on innovation instead of maintaining systems.\u00a0<\/p>\n<p>As Benchling rolls out across the research organization, scientists can design experiments, track samples, and analyze results within a single system, eliminating the friction of disconnected tools. The platform also addresses a long-standing industry challenge: integrating both structured and unstructured data across diverse research environments, laying the groundwork for AI-driven analysis across therapeutic areas.<\/p>\n<p>Through this collaboration, the two companies are redefining how modern biotech research is done, setting a new standard for the digital infrastructure behind AI-driven R&amp;D.<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-22962","post","type-post","status-publish","format-standard","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/22962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22962"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/22962\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}